Abstract
Drug delivery systems are designed to improve therapy efficacy as well as patient compliance. This could be accomplished by specifically targeting a medication intact to its active site, therefore reducing side-effects and enabling high local drug concentrations. Silica nanoparticles have gained ground in the biomedical field for their biocompatibility and biodegradability, being themselves inert and stable, thus enabling a variety of formulation designs for application in the pharmaceutical industry. This paper is a review of the recent patents on the applications of silica nanoparticles for drug delivery and their preparation. The review will focus on the different techniques available to obtain silica nanoparticles with variable morphology and their drug targeting applications, providing an overview of silica particles synthesis described in the literature.
Keywords: Drug delivery, controlled release, hollow silica nanoparticles, nanoparticles, silica, silica aerogels, targeted delivery, synthetic polymer, lower toxic effects, fabricate, biodegradability, polymorphonuclear leukocytes, porosity change, HSNP, TEOS
Recent Patents on Biotechnology
Title: Recent Patents on the Synthesis and Application of Silica Nanoparticles for Drug Delivery
Volume: 5 Issue: 1
Author(s): Maria Lucia Foglia, Gisela Solange Alvarez, Paolo Nicolas Catalano, Andrea Mathilde Mebert, Luis Eduardo Diaz, Thibaud Coradin and Martin Federico Desimone
Affiliation:
Keywords: Drug delivery, controlled release, hollow silica nanoparticles, nanoparticles, silica, silica aerogels, targeted delivery, synthetic polymer, lower toxic effects, fabricate, biodegradability, polymorphonuclear leukocytes, porosity change, HSNP, TEOS
Abstract: Drug delivery systems are designed to improve therapy efficacy as well as patient compliance. This could be accomplished by specifically targeting a medication intact to its active site, therefore reducing side-effects and enabling high local drug concentrations. Silica nanoparticles have gained ground in the biomedical field for their biocompatibility and biodegradability, being themselves inert and stable, thus enabling a variety of formulation designs for application in the pharmaceutical industry. This paper is a review of the recent patents on the applications of silica nanoparticles for drug delivery and their preparation. The review will focus on the different techniques available to obtain silica nanoparticles with variable morphology and their drug targeting applications, providing an overview of silica particles synthesis described in the literature.
Export Options
About this article
Cite this article as:
Lucia Foglia Maria, Solange Alvarez Gisela, Nicolas Catalano Paolo, Mathilde Mebert Andrea, Eduardo Diaz Luis, Coradin Thibaud and Federico Desimone Martin, Recent Patents on the Synthesis and Application of Silica Nanoparticles for Drug Delivery, Recent Patents on Biotechnology 2011; 5 (1) . https://dx.doi.org/10.2174/187220811795655887
DOI https://dx.doi.org/10.2174/187220811795655887 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Functional Properties of Kefiran in the Medical Field and Food Industry
Current Pharmaceutical Biotechnology Stopping Cancer in its Tracks: Using Small Molecular Inhibitors to Target Glioblastoma Migrating Cells
Current Drug Discovery Technologies Critical Steps in Tissue Processing in Histopathology
Recent Patents on DNA & Gene Sequences Perinatal Management of Fetal Tumors
Current Pediatric Reviews Involvement of Toll-like Receptors in Ischemia-induced Neuronal Damage
Central Nervous System Agents in Medicinal Chemistry Molecular Targets for Epigenetic Therapy of Cancer
Current Pharmaceutical Biotechnology Targeting the L-Arginine-Nitric Oxide Pathway for Cancer Treatment
Current Pharmaceutical Design Green Tea Polyphenols as Proteasome Inhibitors: Implication in Chemoprevention
Current Cancer Drug Targets ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy
Current Drug Targets Evidence of PKC Binding and Translocation to Explain the Anticancer Mechanism of Chlorogenic Acid in Breast Cancer Cells
Current Molecular Medicine Tumor-Derived Exosomes Contain microRNAs with Immunological Function: Implications for a Novel Immunosuppression Mechanism
MicroRNA Intracellular Proton Pumps as Targets in Chemotherapy: V-ATPases and Cancer
Current Pharmaceutical Design Engineered Nanoparticles for Improved Vasoactive Intestinal Peptide (VIP) Biomedical Applications
Recent Patents on Nanomedicine Peptides as Therapeutic Agents or Drug Leads for Autoimmune, Hormone Dependent and Cardiovascular Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Determining the Relative Gene Expression Level of Hypoxia Related Genes in Different Cancer Cell Lines
Current Molecular Pharmacology Modulators of Inhibitor of Growth (ING) Family Expression in Development and Disease
Current Drug Targets Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between <i>H. pylori</i> Infection and Low-Dose Aspirin Use
Current Pharmaceutical Design Synthesis and Applications of Hydrogels in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry The Role of TNF and Its Family Members in Inflammation and Cancer: Lessons from Gene Deletion
Current Drug Targets - Inflammation & Allergy Prevention of Cardiovascular Diseases with Anti-Inflammatory and Anti- Oxidant Nutraceuticals and Herbal Products: An Overview of Pre-Clinical and Clinical Studies
Recent Patents on Inflammation & Allergy Drug Discovery